ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CYBG Ve Bionic Etf

16.961
0.00 (0.00%)
Last Updated: 16:07:07
Delayed by 15 minutes
Name Symbol Market Type
Ve Bionic Etf LSE:CYBG London Exchange Traded Fund
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 16.961 17.018 17.21 0 16:07:07

EUROPE MARKETS: European Stocks Close Quarter With Stronger Gain Than U.S.

30/09/2019 5:01pm

Dow Jones News


Ve Bionic Etf (LSE:CYBG)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Ve Bionic Etf Charts.

By Steve Goldstein, MarketWatch

European stocks on Monday ended the quarter with a mild gain, capping three months of turmoil on the political and economic front.

Up 0.35% to 393.15 on the day, the Stoxx Europe 600 index has climbed 2.2% for the quarter. The U.S. S&P 500 is up 1.2% over the same period.

European stocks are much cheaper than their U.S. counterparts, reflecting worries about the area's low growth. According to J.P. Morgan data, the Euro Stoxx 50 has a price-to-earnings ratio of 14.6, compared to 18.1 times for S&P 500 components.

Top gainers in Europe for the July-to-September period include telecoms group Altice Europe (ATC.AE) , French supermarket chain Casino Guichard (CO.FR) and U.K. aerospace firm Cobham (COB.LN), each with gains of over 40%.

Losers included software firm Micro Focus International (MCRO.LN) , down 47% over the last three months, U.K. bank CYBG (CYBG.LN) , which has dropped 42%, and steel maker Evraz (EVR.LN) , down 32%.

The German DAX rose 0.38% to 12428.08, the French CAC 40 gained 0.66% to 5677.79 while the U.K. FTSE 100 declined 0.24% to 7408.21.

Attention is turning to U.S.-China trade talks scheduled for October. A Treasury Department spokeswoman over the weekend said there no current plans to block Chinese companies from listing in the U.S., after a published report unsettled markets on Friday.

Read:U.S.-China talks in October won't stop tariff hikes, but more progress could arrive in November, Morgan Stanley says (http://www.marketwatch.com/story/us-china-talks-in-october-wont-stop-tariff-hikes-but-more-progress-could-arrive-in-november-morgan-stanley-says-2019-09-30)

Whitbread (WTB.LN) shares fell 3.9% as Barclays downgraded the U.K. owner of Premier Inn low cost hotels to equal-weight, with the bank saying the firm's investment case is "muddled."

Swedish Orphan Biovitrum (SOBI.SK) slumped nearly 6% after reaching a pact to buy Dova Pharmaceuticals (DOVA) .

Electricite de France (EDF.FR) shares rose 1.9% after the power firm said it will receive about 400 million euros in compensation for closing a nuclear power plant early.

Related: Here's what Goldman Sachs says a Brexit deal would do to British pound, U.K. stocks (http://www.marketwatch.com/story/heres-what-goldman-sachs-says-a-brexit-deal-would-do-to-british-pound-uk-stocks-2019-09-30)

Related:Why JPMorgan says it's time to switch to Europe stocks from U.S (http://www.marketwatch.com/story/why-jpmorgan-says-its-time-to-switch-to-europe-stocks-from-us-2019-09-30).

 

(END) Dow Jones Newswires

September 30, 2019 11:46 ET (15:46 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

1 Year Ve Bionic Etf Chart

1 Year Ve Bionic Etf Chart

1 Month Ve Bionic Etf Chart

1 Month Ve Bionic Etf Chart

Your Recent History

Delayed Upgrade Clock